Evidence map›Paper›PMID 36678047›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Quantum Optical Effective-Medium Theory for Layered Metamaterials at Any Angle of Incidence.

Ehsan Amooghorban, Martijn Wubs

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ehsan AmooghorbanFaculty of Science, Department of Physics, Shahrekord University, P.O. Box 115, Shahrekord 88186-34141, Iran.ORCID 0000-0003-4035-0366
Martijn WubsDepartment of Electrical and Photonics Engineering, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.ORCID 0000-0002-8286-7825

Funding

Danish National Research Foundation, Center for Nanostructured Graphene DNRF103Danish National Research Foundation, NanoPhoton - Center for Nanophotonics DNRF147Independent Research Fund Denmark - Natural Sciences 0135-00403BIndependent Research Fund Denmark - Natural Sciences FNU 1323-00087Shahrekord UniversityVillum Foundation VKR Centre of Excellence NATEC-II
6 · The paper itself

Abstract

The quantum optics of metamaterials starts with the question of whether the same effective-medium theories apply as in classical optics. In general, the answer is negative. For active plasmonics but also for some passive metamaterials, we show that an additional effective-medium parameter is indispensable besides the effective index, namely, the effective noise-photon distribution. Only with the extra parameter can one predict how well the quantumness of states of light is preserved in the metamaterial. The fact that the effective index alone is not always sufficient and that one additional effective parameter suffices in the quantum optics of metamaterials is both of fundamental and practical interest. Here, from a Lagrangian description of the quantum electrodynamics of media with both linear gain and loss, we compute the effective noise-photon distribution for quantum light propagation in arbitrary directions in layered metamaterials, thereby detailing and generalizing our previous work. The effective index with its direction and polarization dependence is the same as in classical effective-medium theories. As our main result, we derive both for passive and for active media how the value of the effective noise-photon distribution too depends on the polarization and propagation directions of the light. Interestingly, for

Indexed as

effective-medium theoryloss-compensated metamaterialsquantum optics

Identifiers

PMID36678047
PMCPMC9861691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.